Insider Transactions in Q4 2024 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Eiry Roberts Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,345
+5.52%
|
$624,325
$85.2 P/Share
|
|
Nov 04
2024
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.55%
|
-
|
|
Oct 03
2024
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,295
-77.45%
|
$146,335
$113.66 P/Share
|